Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04901741 |
|---|---|
| Brief Title: | Olaptesed With Pembrolizumab and Nanoliposomal Irinotecan or Gemcitabine/Nab-Paclitaxel in MSS Pancreatic Cancer (OPTIMUS) |
| First Submitted : | May 20, 2021 |
| First Submitted that Met QC Criteria : | May 20, 2021 |
| First Posted : | May 25, 2021 |
| Last Update Submitted that Met QC Criteria : | January 30, 2024 |
| Last Update Posted : | February 1, 2024 |